Occlusive renovascular disease caused by atherosclerotic renal artery stenosis (ARAS)
elicits complex biological responses that eventually lead to loss of kidney function. Recent …

Various strategies have been developed to construct albumin nanomaterials via biophysical
or chemical changes. In this work, a compound comprising albumin-paclitaxel nanoparticles …

The impact of coronary artery stenosis (CAS) on renal injury is unknown. Here we tested
whether the existence of CAS, regardless of concurrent atherosclerosis, would induce …

Unlike endovascular therapeutic studies for atherosclerosis in many other vascular beds,
major trials regarding endovascular renovascular revascularization have resulted in a …

Renovascular hypertension: is there still a role for stent r... : Current Opinion in Nephrology and
Hypertension Renovascular hypertension: is there still a role for stent revascularization …

2 Kloner Mitochondrial Protective Agents had no beneficial effects on either infarct size or no
reflow. The end points of this clinical trial included myocardial infarct size as assessed by …

Energy depletion increases the renal production of 2′, 3′-cAMP (a positional isomer of
3′, 5′-cAMP that opens mitochondrial permeability transition pores) and 2′, 3′-cAMP is …

Experimental studies and pilot clinical trials suggest that therapies targeting renal
inflammation, microvascular remodeling, and mitochondrial damage have the potential to …

Percutaneous transluminal renal angioplasty (PTRA) has been used to treat renovascular
disease (RVD), a chronic condition characterized by renal ischemia and metabolic …

Related US Application Data Continuation of application No. 13/247,648, filed on Sep. 28,
2011, now Pat. No. 8,404,646, which is a continuation of application No. 12/753,403, filed on …